A synthetic peptide for use as a blocking control in assays to test for specificity of APLNR antibody, Alternative Names: APLNR control peptide, APLNR antibody Blocking Peptide, Anti-APLNR Blocking Peptide, apelin receptor Blocking Peptide, AGTRL1 Blocking Peptide, APJ Blocking Peptide, APJR Blocking Peptide, FLJ90771 Blocking Peptide, FLJ96609 Blocking Peptide, HG11 Blocking Peptide, MGC45246 Blocking Peptide
APLNR
Reaktivität: Human, Maus, Ratte, Huhn
Wirt: Synthetic
BP
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
Apelin Receptor (APLNR)
Hintergrund
This gene encodes a member of the G protein-coupled receptor gene family. The encoded protein is related to the angiotensin receptor, but is actually an apelin receptor that inhibits adenylate cyclase activity and plays a counter-regulatory role against the pressure action of angiotensin II by exerting hypertensive effect. It functions in the cardiovascular and central nervous systems, in glucose metabolism, in embryonic and tumor angiogenesis and as a human immunodeficiency virus (HIV-1) coreceptor. Two transcript variants resulting from alternative splicing have been identified.